News PBM cuts insulin co-pay as lawmaker confrontations loom Express Scripts has announced a plan to cut patient co-pays for insulin products at $25 a month ahead of a pricing showdown with US politicians next week.
News One Drop and MannKind team for inhalable insulin trial Trial to investigate One Drop's diabetes management solution with MannKind's Afrezza.
News Oral insulin could still be a reality, says Novo Nordisk Last October Novo Nordisk announced that it had shelved plans to bring the world’s first oral insulin to market .
News Novo hopes hypoglycaemia data will boost Tresiba Lower severe hypo risk compared with Lantus - but no cardiac benefit.
News Lilly and Boehringer biosimilar undercuts Lantus by 15% Sanofi under pressure following long-awaited biosimilar launch.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.